Tony Piscopio, chairman and CEO of Optomagic, said: “We are pleased that Takeda has decided to further expand its partnership with Chemizon. With our recently announced strategic partnership in the area of oncology, we anticipate working with our partners and leveraging our integrated Discovery Platform.”